Hjem › Blærekreft › New York

Kliniske studier for Blærekreft i New York

41 studier for Blærekreft søker deltakere på steder i New York.

Byer i New York

Offisiell studietekst (engelsk)

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
og 2 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06465069

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

Memorial Sloan Kettering Cancer Center ( Site 5031), New York

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07232602

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
og 3 flere

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07000084

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen

Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
og 1 flere

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06770582

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06833073

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

The New York Hospital Medical Center of Queens, Flushing
NYP/Weill Cornell Medical Center, New York
Stony Brook University Medical Center, Stony Brook

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
og 3 flere

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

New York Oncology Hematology, Albany
New York Oncology Hematology, Clifton Park
Icahn School of Medicine at Mount Sinai, New York

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07421700

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

MSK Commack, Commack
MSK Westchester, Harrison
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
og 9 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07206225

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Columbia University Irving Medical Center, New York

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07277413

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

Memorial Sloan Kettering Cancer Center ( Site 0832), New York

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College, New York
og 1 flere

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07218380

A Study of Surgical Techniques During Cystectomy

Memorial Sloan Kettering Suffolk-Commack (Consent Only), Commack
Memorial Sloan Kettering Westchester (Consent Only), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
og 1 flere

RekruttererFase 3

Alder 21 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06703476

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

Roswell Park Comprehensive Cancer Center, Buffalo

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06733363

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Icahn School of Medicine at Mount Sinai, New York
Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07217171

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06644755

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Integrated Medical Professionals, PLLC (Solaris), New York
University of Rochester, Rochester
SUNY Upstate, Syracuse
og 2 flere

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06567743

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
og 1 flere

Rekrutterer

Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05837767

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
University of Rochester, Department of Urology, Rochester
Associated Medical Professionals of NY, PLLC, Syracuse
og 1 flere

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

New York University (NYU), New York
Weill Cornell Medicine, New York
Icahn School of Medicine at Mount Sinai, New York
og 4 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05614739

Measuring Surgical Recovery After Radical Cystectomy

Winthrop University Hospital, Mineola
University of Rochester, Rochester

RekruttererObservasjonsstudie

Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT03193970

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
og 4 flere

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07097142

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06242470

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Albany Medical College, Albany
Roswell Park Cancer Institute, Buffalo
Mount Sinai Medical Center, New Haven
og 1 flere

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT04752722

A Study of a Side Effects and Resource Navigation Program for People With Cancer

Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
City College of New York (Data Collection AND Specimen Analysis), New York
og 2 flere

Rekrutterer

Alder 18 og eldre · Alle kjønn · Oppdatert 31. jul. 2026 · NCT07646847

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

RekruttererFase 2/3

Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

RekruttererFase 2

Alder 8 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05503797

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, Albany
Research Site, New York

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT07720284

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

MSK Commack, Commack
MSK Wesrchester, Harrison
Memorial Sloan Kattering Cancer Centre- Investigational Drug Service Pharmacy, Long Island City
og 6 flere

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT04879329

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
og 7 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT04389632